Recombinant Activated Factor VII in Cardiac Surgery: Experience From the Australian and New Zealand Haemostasis Registry Scott Dunkley, BMed, FRACP, Louise Phillips, BSc (Hons), PhD, Peter McCall, MBBS, FANZCA, John Brereton, MBBS, FRACS, Robert Lindeman, MBBS (Hons), BSc (Med), Gary Jankelowitz, MBBch, MBA, Peter Cameron, MBBS, MD The Annals of Thoracic Surgery Volume 85, Issue 3, Pages 836-844 (March 2008) DOI: 10.1016/j.athoracsur.2007.06.076 Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Effect of activated recombinant factor VII on bleeding versus outcome (deceased, vertical pattern; living, diagonal pattern) at 28 days (χ22 = 22.3; p < 0.001). The Annals of Thoracic Surgery 2008 85, 836-844DOI: (10.1016/j.athoracsur.2007.06.076) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions